Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Janssen Research & Development, LLC
Efstathios Kastritis; Giovanni Palladini; Monique C Minnema; Ashutosh D Wechalekar; Arnaud Jaccard; Hans C Lee; Vaishali Sanchorawala; Simon Gibbs; Peter Mollee; Christopher P Venner; Jin Lu; Stefan Schönland; Moshe E Gatt; Kenshi Suzuki; Kihyun Kim; M Teresa Cibeira; Meral Beksac; Edward Libby; Jason Valent; Vania Hungria; Sandy W Wong; Michael Rosenzweig; Naresh Bumma; Antoine Huart; Meletios A Dimopoulos; Divaya Bhutani; Adam J Waxman; Stacey A Goodman; Jeffrey A Zonder; Selay Lam; Kevin Song; Timon Hansen; Salomon Manier; Wilfried Roeloffzen; Krzysztof Jamroziak; Fiona Kwok; Chihiro Shimazaki; Jin-Seok Kim; Edvan Crusoe; Tahamtan Ahmadi; NamPhuong Tran; Xiang Qin; Sandra Y Vasey; Brenda Tromp; Jordan M Schecter; Brendan M Weiss; Sen H Zhuang; Jessica Vermeulen; Giampaolo Merlini; Raymond L Comenzo; ANDROMEDA Trial Investigators